相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome
Kleio-Maria Verrou et al.
JOURNAL OF AUTOIMMUNITY (2023)
Deregulated DNA damage response network in Behcet?s disease
Nikolaos I. Vlachogiannis et al.
CLINICAL IMMUNOLOGY (2023)
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
George C. Drosos et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance
Thomas Foret et al.
RHEUMATOLOGY (2022)
Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome
Jason S. Knight et al.
SEMINARS IN IMMUNOPATHOLOGY (2022)
Growth differentiation factor 15 (GDF-15) as potential cardiovascular risk biomarker in antiphospholipid syndrome
Maria G. Tektonidou et al.
RHEUMATOLOGY (2022)
Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis
Maria G. Tektonidou
JOURNAL OF AUTOIMMUNITY (2022)
Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome
Bruna de Moraes Mazetto et al.
THROMBOSIS RESEARCH (2022)
Clinical value of amyloid-beta1-40 as a marker of thrombo-inflammation in antiphospholipid syndrome
Maria G. Tektonidou et al.
RHEUMATOLOGY (2021)
Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome
Manuela Velasquez et al.
FRONTIERS IN PHYSIOLOGY (2021)
Therapeutic Potential and Immunomodulatory Role of Coenzyme Q10 and Its Analogues in Systemic Autoimmune Diseases
Chary Lopez-Pedrera et al.
ANTIOXIDANTS (2021)
New insights into abasic site repair and tolerance
Petria S. Thompson et al.
DNA REPAIR (2020)
Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity
Themis Alissafi et al.
CELL METABOLISM (2020)
Anti-Neutrophil Extracellular Trap Antibodies and Impaired Neutrophil Extracellular Trap Degradation in Antiphospholipid Syndrome
Yu Zuo et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis
Nikolaos I. Vlachogiannis et al.
FRONTIERS IN IMMUNOLOGY (2020)
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis Update of the guidelines for lupus anticoagulant detection and interpretation
Katrien M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
DNA damage accumulation, defective chromatin organization and deficient DNA repair capacity in patients with rheumatoid arthritis
Vassilis L. Souliotis et al.
CLINICAL IMMUNOLOGY (2019)
Statin treatment, oxidative stress and inflammation in a Danish population
Anders L. Sorensen et al.
REDOX BIOLOGY (2019)
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Type I interferon gene expression in antiphospholipid syndrome: Pathogenetic, clinical and therapeutic implications
Eleni Xourgia et al.
JOURNAL OF AUTOIMMUNITY (2019)
Independent association of low IFNλ1 gene expression and type I IFN score/IFNλ1 ratio with obstetric manifestations and triple antiphospholipid antibody positivity in primary antiphospholipid syndrome
Christina-Maria Flessa et al.
CLINICAL IMMUNOLOGY (2019)
Stress Marks on the Genome: Use or Lose?
Bayan Bokhari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
Francesco Tedesco et al.
FRONTIERS IN IMMUNOLOGY (2018)
Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome
Robert C. Grenn et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Formation and repair of oxidatively generated damage in cellular DNA
Jean Cadet et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Antiphospholipid Syndrome Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics
Michel T. Corban et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile A Randomized, Placebo-Controlled Trial
Carlos Perez-Sanchez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt
Alshaymaa Ahmed Ibrahim et al.
CLINICAL RHEUMATOLOGY (2017)
Pleiotropic Effects of Statins on the Cardiovascular System
Adam Oesterle et al.
CIRCULATION RESEARCH (2017)
Occurrence, Biological Consequences, and Human Health Relevance of Oxidative Stress-Induced DNA Damage
Yang Yu et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches
Chary Lopez-Pedrera et al.
RHEUMATOLOGY (2016)
Histone H2AX phosphorylation as a measure of DNA double-strand breaks and a marker of environmental stress and disease activity in lupus
Rajaie Namas et al.
LUPUS SCIENCE & MEDICINE (2016)
Glutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1)
Koji Aoyama et al.
MOLECULES (2015)
The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where
Ioannis S. Pateras et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R. Cervera et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q10 treatment
Carlos Perez-Sanchez et al.
BLOOD (2012)
Mechanisms of free radical-induced damage to DNA
Miral Dizdaroglu et al.
FREE RADICAL RESEARCH (2012)
Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome
Marietta Charakida et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
DNA damage and repair: From molecular mechanisms to health implications
Fabio Altieri et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model
JD Alves et al.
RHEUMATOLOGY (2005)
Oxidative DNA damage and disease: induction, repair and significance
MD Evans et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2004)
Oxidative DNA damage: mechanisms, mutation, and disease
MS Cooke et al.
FASEB JOURNAL (2003)
Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies:: effect of antioxidant treatment
D Ferro et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome
JD Alves et al.
IMMUNOBIOLOGY (2003)
Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies
M Lambert et al.
LUPUS (2000)
分享论文
